Haematology

Bristol-Myers Squibb announced that the FDA has accepted for Priority Review its Biologics License Application (BLA) for lisocabtagene maraleucel (liso-cel), the company's autologous anti-CD19 chimeric antigen receptor (CAR) T-cell immunotherapy

Biotronik has announced CE Mark certification for the Orsiro Mission drug-eluting stent (DES) system. The next generation of the company's ultrathin strut Orsiro DES provides higher deliverability than other contemporary stents. Orsiro Mission is now available in CE Mark countries.

Purpose: Ventral incisional hernias, especially large and giant, carry significant post repair complications. This retrospective review is undertaken to determine...

These updated guidelines on the management of variceal haemorrhage have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under the auspices of the liver section of the BSG.